Position in LLY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,596,010,657
New position
Shares Held
1,735,228
first reported quarter
Ownership
0.184%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Vanguard Global Advisers, LLC holds $6,015,052,218 across 13 Drug Manufacturers - General names. LLY ranks #1 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,735,228 | $1,596,010,657 | |
| 2 | JNJ |
Johnson & Johnson
|
5,306,356 | $1,297,085,660 | |
| 3 | ABBV |
AbbVie Inc.
|
3,905,658 | $849,441,558 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,585,694 | $671,903,131 | |
| 5 | AMGN |
Amgen Inc
|
1,184,750 | $416,854,287 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,768,304 | $385,818,528 | |
| 7 | PFE |
Pfizer Inc
|
12,905,896 | $362,397,559 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,734,916 | $287,172,655 |
All Filings in LLY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,596,010,657 | 1,735,228 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||